Physician profile
Joseph Chidi
NPI 1366448318
$923.43
in general payments reported to CMS, 2019-2025
24 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $734 · 2020: $190.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $263.40 | 2019-2020 | |
| Janssen Biotech, INC. | $65.17 | 2019 | |
| Karl Storz Endoscopy-America | $56.28 | 2019 | |
| Eisai INC. | $52.83 | 2019-2020 | |
| Abbvie INC. | $51.38 | 2019-2020 | |
| Endo Pharmaceuticals INC. | $48.40 | 2019-2020 | |
| Coloplast Corp | $43.35 | 2019 | |
| Boston Scientific Corporation | $32.43 | 2019 | |
| Ferring Pharmaceuticals INC. | $30.18 | 2019 | |
| 180 Medical, INC. | $26.40 | 2020 | |
| Genzyme Corporation | $22.45 | 2019 | |
| Photocure INC | $22.00 | 2019 | |
| Glaxosmithkline, LLC. | $21.95 | 2019 | |
| Amgen INC. | $21.67 | 2019 | |
| Richard Wolf Medical Instruments Corp. | $20.52 | 2019 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Livanova USA, INC. | $19.16 | 2019 | |
| Rochester Medical Corporation | $18.89 | 2019 | |
| Pfizer INC. | $18.71 | 2019 | |
| Tolmar Pharmaceuticals, INC. | $18.57 | 2019 | |
| Aquestive Therapeutics, INC. | $18.18 | 2020 | |
| Dendreon Pharmaceuticals LLC | $16.47 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $16.36 | 2019 | |
| Lilly USA, LLC | $11.30 | 2020 | |
| Travere Therapeutics, INC. | $7.38 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Chidi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.